FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to a drug with hepatoprotective activity. The agent with hepatoprotective activity is a colloidal solution containing water, humic substances representing humic and fulvic acids and their salts, hydroquinone and chrysin, and the size of colloidal particles is in the range from 30 nm to 10 microns, the mass of humic substances is from 1 to 20 wt. % hydroquinone is contained in an amount not exceeding 3 wt. % of the mass of humic substances, and chrysin in an amount not exceeding 2 wt. % of the mass of humic substances.
EFFECT: humic agent described above contains a wide range of humic substances and has no chemical impurities, it is effective as a hepatoprotective agent.
1 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DETOXIFYING HUMIC AGENT | 2020 |
|
RU2756354C1 |
| ADAPTOGENIC HUMIC AGENT | 2021 |
|
RU2775079C1 |
| ANTICOAGULATION HUMIC AGENT FOR IMPROVING RHEOLOGICAL PROPERTIES OF BLOOD | 2020 |
|
RU2756364C1 |
| ANTIVIRAL HUMIC AGENT | 2020 |
|
RU2753609C1 |
| ANTI-INFLAMMATORY HUMIC AGENT | 2020 |
|
RU2756363C1 |
| IMMUNOMODULATING HUMIC AGENT | 2020 |
|
RU2756353C1 |
| ANTIBACTERIAL HUMIC AGENT | 2020 |
|
RU2753606C1 |
| METHOD OF PRODUCING HUMIC SUBSTANCE EXTRACT | 2019 |
|
RU2720308C1 |
| METHOD FOR PREVENTION OF GASTRIC MUCOSA ULCERATION | 2011 |
|
RU2481111C1 |
| AGENT FOR NORMALIZING METABOLIC PROCESSES IN METABOLIC DISORDERS IN CATTLE | 2019 |
|
RU2731404C1 |
